socaltech | Shared With: Everyone - Aug 08 2006 | cabrellis, cancer, lung, domain, associates, venture, capital, vc, investment, funding, anthracycline, socaltechSan Diego-based Cabrellis Pharmaceuticals, which is developing treatments for cancer, said Monday that it has raised $27.5M in a Series A funding round. Funding came from Domain Associates, Forward Ventures, Lilly Ventures, Novo A/S, ProQuest Investments,
Related Content from Around Faves
investment
-
This is not too surprising given Japan's dependency on U.S. consumers.
Let's see how this affects the U.S. markets tomorrow.
1 FaverViewed: 3 TimesQuoted: Japan’s economy has been hurt by weak export growth and steep cuts in corporate spending amid the worsening global slowdown.
- ClaraSet - 17 hours ago7 Favers
- ClaraSet - 21 hours ago3 Favers
vcs
-
Interesting
1 FaverViewed: 4 TimesQuoted: The news that some Facebook employees are selling their stock privately naturally focuses on the price/valuation (a deep discount to the $15bn that Microsoft paid).
- mohit - 5 days ago2 FaversViewed: 6 Times
- mohit - Oct 10 20081 FaverViewed: 2 Times
